Magnesium Sulfate Heptahydrate

Excessive neuromuscular block has occurred; these drugs should be administered concomitantly with caution.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Potentiation and prolongation of neuromuscular blockade is possible with concomitant use. Monitor respiration and depth of neuromuscular blockade frequently.

Co-administration may result in hyperkalemia. Monitor serum potassium levels in such patients.

Coadministration may result in hyperkalemia. Monitor serum potassium in such patients.

Co-administration may result in hyperkalemia. Monitor serum potassium in such patients.

Serious changes in cardiac conduction and heart block may occur in digitalized patients; administer with extreme caution.

Potentiation and prolongation of neuromuscular blockade is possible with concomitant use. Monitor respiration and depth of neuromuscular blockade frequently.

May prolong neuromuscular blockade action of cisatracurium besylate. Use peripheral nerve stimulator and monitor clinical signs.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

May lead to significant increases in serum potassium.

Potassium-containing salt substitutes may lead to significant increases in serum potassium when combined with enalapril.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Coadministration may result in hyperkalemia. Monitor serum potassium in such patients.

Concomitant use may lead to increases in serum potassium and hyperkalemia, sometimes severe. Monitor serum potassium.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Potassium-containing salt substitutes may lead to significant hyperkalemia when used with lisinopril which attenuates potassium loss.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Exaggerated hypotensive response is possible with concomitant use. Monitor vital signs frequently; supportive care and/or discontinuation may be required.

Potentiation and prolongation of neuromuscular blockade is possible with concomitant use. Monitor respiration and depth of neuromuscular blockade frequently.

Most salt substitutes contain substantial amounts of potassium; concomitant use could result in hyperkalemia.

Potentiation and prolongation of analgesia and CNS depression is possible. Monitor depth of CNS depression frequently and adjust dosage accordingly.

Potentiation and prolongation of neuromuscular blockade is possible with concomitant use. Monitor respiration and depth of neuromuscular blockade frequently.

Potentiation and prolongation of neuromuscular blockade is possible. Magnesium suppresses peripheral neuromuscular function by decreasing acetylcholine release and reducing endplate sensitivity.

Most contain substantial amounts of potassium; may promote serum potassium accumulation and hyperkalemia when used with triamterene, especially in renal insufficiency.

Salt substitutes containing substantial amounts of potassium may promote serum potassium accumulation and hyperkalemia with triamterene.

Potentiation and prolongation of neuromuscular blockade is possible with concomitant use. Monitor respiration and depth of neuromuscular blockade frequently.

Alcohol induces renal losses of magnesium.

Concomitant use with valsartan may increase serum potassium levels. Monitor potassium concentration.

Amphotericin B induces renal losses of magnesium.

May enhance the neuromuscular blocking action of atracurium.

Additive CNS depressant effects when used with magnesium; dosage should be adjusted with caution.

CNS depression and peripheral transmission defects produced by magnesium may be antagonized by calcium.

Cisplatin induces renal losses of magnesium.

Cyclosporine induces renal losses of magnesium.

Digitalis induces renal losses of magnesium.

Diuretics induce renal losses of magnesium.

May enhance neuromuscular blockade and interfere with restoration of neuromuscular function when used with pyridostigmine.

May lead to increased serum potassium. Monitor potassium levels.

May enhance the neuromuscular blocking action of succinylcholine.

Additive CNS depressant effects when used with magnesium; dosage should be adjusted with caution.

Can increase risk of hyperkalemia when used concomitantly with trandolapril. Use with caution and monitor serum potassium.

Concomitant use with ACE inhibitors increases risk of hyperkalemia. Use with caution and appropriate monitoring of serum potassium.